Natural history of hepatitis C virus infection

被引:34
作者
Amarapurkar, D
机构
[1] Bombay Hosp & Med Res Ctr, Med Res Ctr, Mumbai, India
[2] Inst Postgrad Sci, Mumbai, India
[3] Jagjivan Ram Western Railway Hosp, Mumbai, India
关键词
D O I
10.1046/j.1440-1746.2000.02110.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C is a heterogeneous disease whose natural history is controversial and perplexing. However, it can be a pernicious disease and is responsible for considerable mortality and morbidity. More than 80% individuals infected with the hepatitis C virus (HCV) develop chronic infection; the remaining 10 20% develop spontaneous clearance with natural immunity. The majority of patients who develop chronic HCV infection are asymptomatic; but 60-80% develop chronic hepatitis as indicated by elevated ALT; around 30% maintain normal ALT. One-third of chronically infected patients develop progressive liver injury, fibrosis and cirrhosis over a period of 20-30 years, and 15% develop hepatocellular carcinoma. Acquiring infection after the age of 40 years, male sex, excessive alcohol consumption, HBV or HIV co-infection and the immunosuppressive state have been identified as factors associated with progression of fibrosis and development of cirrhosis. The relationship between virus load, HCV genotype I and quasispecies variability and progression of live disease is controversial. In the present study on 141 patients with chronic HCV infection and established chronic liver disease, the median time to develop cirrhosis was 20 years. Progression to cirrhosis was faster (16 vs 20 gears) in those who acquired infection after the age of 35 years, and in immunosuppressed patients (8 vs 21 years), whereas diabetes, sex and HBV co-infection were not associated with faster progression. (C) 2000 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:E105 / E110
页数:6
相关论文
共 47 条
[1]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[2]  
AMARAPURKAR DN, 1992, IND J GASTROENTEROL, V11, pA5
[3]  
AMARAPURKAR DN, 1998, J GASTROEN HEPATOL, V13, pA4
[4]   Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy [J].
Bonkovsky, HL ;
Woolley, JM .
HEPATOLOGY, 1999, 29 (01) :264-270
[5]  
BRUIX J, 1989, LANCET, V2, P1004
[6]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26
[7]  
Chiba T, 1996, AM J GASTROENTEROL, V91, P1195
[8]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[9]  
COLOMBO M, 1989, LANCET, V2, P1006
[10]   Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C [J].
Darby, SC ;
Ewart, DW ;
Giangrande, PLF ;
Spooner, RJD ;
Rizza, CR ;
Dusheiko, GM ;
Lee, CA ;
Ludlam, CA ;
Preston, FE .
LANCET, 1997, 350 (9089) :1425-1431